SYnAbs
Pre-clinicalDevelops therapeutic antibodies for autoimmune and inflammatory diseases.
Founded
2014
Focus
Antibodies
About
Develops therapeutic antibodies for autoimmune and inflammatory diseases.
Funding History
2Total raised: $13.5M
Series A$10MNovalis BiotechMar 15, 2023
Seed$3.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2014
LocationLiège, Belgium
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Miracor Medical
Pre-clinical · Zaventem
AML Clinical Services
Pre-clinical · Leuven
Anacura
Pre-clinical · Ghent
Aseptic Technologies
Pre-clinical · Gembloux
Aspect Analytics
Pre-clinical · Leuven
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile